down arrow

Sun Pharma.Inds.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE044A01036
  • NSEID: SUNPHARMA
  • BSEID: 524715
INR
1,692.15
40.15 (2.43%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 24.03 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Divi's Lab.
Abbott India
Cipla
Lupin
Zydus Lifesci.
Alkem Lab
Dr Reddy's Labs
Sun Pharma.Inds.
Torrent Pharma
Aurobindo Pharma
Mankind Pharma
Why is Sun Pharmaceutical Industries Ltd ?
1
Stock is technically in a Bearish range
  • The technical trend has deteriorated from Mildly Bearish on 07-Apr-25 and has generated 1.13% returns since then
  • Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
2
With ROE of 16.2, it has a Expensive valuation with a 5.7 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 5.19%, its profits have risen by 25.7% ; the PEG ratio of the company is 1.3
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Sun Pharma.Inds. for you?

Low Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Sun Pharma.Inds.
5.5%
0.25
20.38%
SENSEX
0.45%
0.02
14.48%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
10.32%
EBIT Growth (5y)
20.62%
EBIT to Interest (avg)
52.63
Debt to EBITDA (avg)
0.42
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.70
Tax Ratio
13.72%
Dividend Payout Ratio
33.82%
Pledged Shares
0.69%
Institutional Holding
36.60%
ROCE (avg)
18.52%
ROE (avg)
14.60%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
34
Industry P/E
33
Price to Book Value
5.73
EV to EBIT
31.49
EV to EBITDA
25.96
EV to Capital Employed
7.35
EV to Sales
7.34
PEG Ratio
1.31
Dividend Yield
0.94%
ROCE (Latest)
22.31%
ROE (Latest)
16.22%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

13What is working for the Company
ROCE(HY)

Highest at 18.48 %

PAT(Q)

Highest at Rs 3,168.72 cr.

NET SALES(Q)

Highest at Rs 13,675.46 cr

PBDIT(Q)

Highest at Rs 4,009.02 cr.

PBT LESS OI(Q)

Highest at Rs 3,326.95 cr.

-2What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Sun Pharma.Inds.
Profit After Tax (PAT) - Quarterly
Highest at Rs 3,168.72 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Net Sales - Quarterly
Highest at Rs 13,675.46 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 4,009.02 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 3,326.95 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)